Bridgewealth Advisory Group’s AbbVie ABBV Stock Holding History

Bridgewealth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Sell	1,176 -42	-3%	-$9.04K	0.06%	103
2026 Q1	$265K	Sell	1,218 -87	-7%	-$19.3K	0.06%	105
2025 Q4	$298K	Buy	1,305 +176	+16%	+$40.1K	0.07%	100
2025 Q3	$261K	Buy	1,129 +1	+0.1%	+$204	0.06%	95
2025 Q2	$209K	Buy	+1,128	New	+$210K	0.05%	108
2025 Q1	–	Sell	-1,124	Closed	-$217K	–	51
2024 Q4	$217K	Buy	+1,124	New	+$207K	0.06%	104

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Bridgewealth Advisory Group's ABBV Position: Q2 2026 in Review

Bridgewealth Advisory Group reduced its AbbVie (ABBV) stake by 3.4% in Q2 2026, selling an estimated $9.04K and leaving 1,176 shares worth $296K. The position accounts for 0.06% of the portfolio, ranked #103.

Bridgewealth Advisory Group first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $298K in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bridgewealth Advisory Group held 1,176 shares of AbbVie worth $296K as of Q2 2026.
Bridgewealth Advisory Group sold 42 AbbVie shares in Q2 2026, an estimated $9.04K.
AbbVie made up 0.06% of Bridgewealth Advisory Group's portfolio in Q2 2026, its #103 holding.
Bridgewealth Advisory Group first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Bridgewealth Advisory Group's AbbVie position peaked at $298K in Q4 2025.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bridgewealth Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.